ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9838
0.24%
Brent Oil
83.61
0.08%
Bitcoin
59,512.93
2.17%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Y mAbs Therapeutics Inc (YMAB)

  7. Y mAbs Therapeutics Inc (YMAB) Noticias

YMAB Y mAbs Therapeutics Inc

17.25
0.76 (4.61%)
Fuera de horario
Última actualización: 16:13:18
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Y mAbs Therapeutics Inc YMAB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.76 4.61% 17.25 16:13:18
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
16.49 16.295 17.39 17.25 16.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202406:05GLOBEY-mAbs to Announce First Quarter 2024 Financial and..
25/4/202415:05GLOBEY-mAbs to Present at 2024 ASCO Annual Meeting
14/3/202408:05GLOBEY-mAbs Therapeutics Announces Resignation of Chief Financial..
07/3/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:49EDGAR2Form 144 - Report of proposed sale of securities
06/3/202415:40EDGAR2Form 144 - Report of proposed sale of securities
05/3/202418:05EDGAR2Form 144 - Report of proposed sale of securities
04/3/202406:30GLOBEY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to..
04/3/202405:05EDGAR2Form 8-K - Current report
29/2/202416:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202415:05GLOBEY-mAbs Reports Fourth Quarter and Full Year 2023 Financial..
29/2/202415:04EDGAR2Form 8-K - Current report
16/2/202406:30GLOBEY-mAbs to Announce Fourth Quarter and Full Year 2023..
14/2/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202416:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202416:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202405:45EDGAR2Form 8-K - Current report
02/1/202415:05GLOBEY-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan..
26/12/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202318:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:40EDGAR2Form 144 - Report of proposed sale of securities
13/12/202315:05GLOBEY-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
12/12/202307:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202307:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:07EDGAR2Form 144 - Report of proposed sale of securities
13/11/202315:47EDGAR2Form 8-K - Current report
13/11/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:05GLOBEY-mAbs Reports Third Quarter 2023 Financial Results and..
08/11/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202316:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/10/202306:05GLOBEY-mAbs to Announce Third Quarter 2023 Financial and..
18/10/202315:09EDGAR2Form 8-K - Current report
18/10/202315:05GLOBEY-mAbs Names Michael Rossi as President and Chief Executive..
18/10/202308:00EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
YMAB
Y mAbs Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados